Ildar R. Kabirov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ildar R. Kabirov has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Valentin Nikolaevich Pavlov
Башкирский государственный медицинский университет
8 shared publications Li Peng
Harbin Medical University
3 shared publications- Wanhai Xu
Department of Urology, The Second Affiliated Hospital, Harbin Medical University
3 shared publications - Alisa Nasibullina
Bashkir State Medical Universitey
2 shared publications - Damir Valishin
Bashkirian State Medical University
2 shared publications - Diana Kh. Gainullina
Bashkir State Medical University
2 shared publications
Latest Publications
- 7 May 2025
- Published by ECO-Vector LLC (Publications) in Urology Reports (St. - Petersburg)
- Vol. 15 (1) , 75-88
Reprogramming the immune response in prostate cancer treatment
Prostate cancer is the most common malignant disease among men, accounting for approximately 29% of all cancer cases in males. Recent research in the prostate cancer treatment has shown that immunotherapy can significantly improve the quality of treatment, extend remission, and enhance patient survival. However, the tumor microenvironment can negatively affect the efficacy of immunotherapy. Insufficient T-cell infiltration, immunosuppressive microenvironment, tumor-associated T and B lymphocytes, macrophages, and myeloid-derived suppressor cells substantially reduce the efficacy of immunotherapy. Current immunotherapy strategies include vaccine-based approaches, immune checkpoint inhibitors, CAR T-cell therapy, T-cell activators, etc. This review highlights the key therapeutic approaches aimed at reprogramming the immune response in prostate cancer, including nucleic acid-based vaccines, peptide-based vaccines, viral vector-based vaccines, immune cell-based vaccines, checkpoint inhibitors, CAR T-cell therapy, and bispecific antibodies. It also presents clinical and preclinical data on these therapies. Current immunotherapy approaches demonstrate significant potential in activating and directing the immune response against tumor cells. However, further research is required to better understand the underlying mechanisms and to develop new therapeutic strategies.
- 7 May 2025
- Published by ECO-Vector LLC (Publications) in Urology Reports (St. - Petersburg)
- Vol. 15 (1) , 75-88
Reprogramming the immune response in prostate cancer treatment
Prostate cancer is the most common malignant disease among men, accounting for approximately 29% of all cancer cases in males. Recent research in the prostate cancer treatment has shown that immunotherapy can significantly improve the quality of treatment, extend remission, and enhance patient survival. However, the tumor microenvironment can negatively affect the efficacy of immunotherapy. Insufficient T-cell infiltration, immunosuppressive microenvironment, tumor-associated T and B lymphocytes, macrophages, and myeloid-derived suppressor cells substantially reduce the efficacy of immunotherapy. Current immunotherapy strategies include vaccine-based approaches, immune checkpoint inhibitors, CAR T-cell therapy, T-cell activators, etc. This review highlights the key therapeutic approaches aimed at reprogramming the immune response in prostate cancer, including nucleic acid-based vaccines, peptide-based vaccines, viral vector-based vaccines, immune cell-based vaccines, checkpoint inhibitors, CAR T-cell therapy, and bispecific antibodies. It also presents clinical and preclinical data on these therapies. Current immunotherapy approaches demonstrate significant potential in activating and directing the immune response against tumor cells. However, further research is required to better understand the underlying mechanisms and to develop new therapeutic strategies.
- Open Access
- 1 April 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (1) , 50-56
Biopolymer crosslinking: Application and prospects
Crosslinking is a method of linking together high-molecular compounds by forming new chemical cross linkages inside and between macrochains. At the same time, various agents can act as cross linkers, i.e., chemical compounds, ultraviolet radiation, etc. Crosslinking of biotissues is known for improving their mechanical strength, increasing structural density, and reducing bioscaffold permeability. This review aims to characterize possible applications of cross-linking technology in various branches of medicine, i.e., ophthalmology, traumatology, urology, gastroenterology, oncology, bioengineering, and others. A review of domestic and foreign publications was carried out using the database and resources of search systems of scientific electronic libraries such as PubMed, elibrary.ru, Google Scholar, Science Direct, and the library stock of Bashkir State Medical University for the period from 1994 to 2023. The study of available literature sources makes it possible to conclude that the method of ultraviolet crosslinking is currently widely used in ophthalmology, while various modifications of crosslinking have prospects in medicine and related industries and can become the basis for the creation of bioengineered products and original medical technologies aimed at improving the effectiveness of treatment of various human diseases.
- 1 April 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (1) , 50-56
Open AccessBiopolymer crosslinking: Application and prospects
Crosslinking is a method of linking together high-molecular compounds by forming new chemical cross linkages inside and between macrochains. At the same time, various agents can act as cross linkers, i.e., chemical compounds, ultraviolet radiation, etc. Crosslinking of biotissues is known for improving their mechanical strength, increasing structural density, and reducing bioscaffold permeability. This review aims to characterize possible applications of cross-linking technology in various branches of medicine, i.e., ophthalmology, traumatology, urology, gastroenterology, oncology, bioengineering, and others. A review of domestic and foreign publications was carried out using the database and resources of search systems of scientific electronic libraries such as PubMed, elibrary.ru, Google Scholar, Science Direct, and the library stock of Bashkir State Medical University for the period from 1994 to 2023. The study of available literature sources makes it possible to conclude that the method of ultraviolet crosslinking is currently widely used in ophthalmology, while various modifications of crosslinking have prospects in medicine and related industries and can become the basis for the creation of bioengineered products and original medical technologies aimed at improving the effectiveness of treatment of various human diseases.
- Open Access
- 1 April 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (1) , 66-71
Robotic-assisted Burch operation using an alloplant for urinary incontinence: Clinical case
Introduction. Urinary incontinence is an urgent problem in urogynecology and the number of patients with this pathology is steadily increasing. The main treatment method of urinary incontinence in women includes synthetic suburethral slings. Currently, more than 200 operations for stress urinary incontinence are carried out. One of the methods of surgical treatment of this pathology implies Burch colposuspension, which has been considered the gold standard treatment of stress urinary incontinence for recent decades. Aim. This study aims to describe a clinical case of using an alloplant in a robotic-assisted Burch operation for urinary incontinence.Materials and methods. A 48-year-old patient was admitted to the BSMU Clinic in a planned manner with complaints of urinary incontinence during coughing, sneezing, and physical exertions as well as of a feeling of a foreign body in the vagina. The examination results confirmed a diagnosis of stress urinary incontinence. Comorbidities: Pelvic floor weakness. 2–3 degrees omission of the anterior vaginal wall. Cystocele. POP-Q 2. It was decided to perform a robotic-assisted Burch operation using an alloplant.Results and discussion. The postoperative period proceeded without complications. A Foley’s catheter was removed on the first day. After its removal, natural urination was restored. The stitches were removed on the fifth day. The wound healed by primary intention healing. Urine was retained well during functional tests. On the 7th and 30th days, magnetic resonance imaging (MRI) revealed no inflammatory processes at the fixation site of the allograft. The allograft was retained, its integrity was preserved, and no pathology was detected. Patient examination at a distant time after surgery (2, 4, and 12 months) revealed that the function of the bladder to hold urine was preserved.Conclusion. Robotic colposuspension using an alloplant is safe and can significantly improve quality of life indicators. The main advantages of this operation include the absence of allograft deformation and disease recurrence during patient examination as well as slighter injuries to the paraurethral tissues assisting the bladder in holding urine.
- 1 April 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (1) , 66-71
Open AccessRobotic-assisted Burch operation using an alloplant for urinary incontinence: Clinical case
Introduction. Urinary incontinence is an urgent problem in urogynecology and the number of patients with this pathology is steadily increasing. The main treatment method of urinary incontinence in women includes synthetic suburethral slings. Currently, more than 200 operations for stress urinary incontinence are carried out. One of the methods of surgical treatment of this pathology implies Burch colposuspension, which has been considered the gold standard treatment of stress urinary incontinence for recent decades. Aim. This study aims to describe a clinical case of using an alloplant in a robotic-assisted Burch operation for urinary incontinence.Materials and methods. A 48-year-old patient was admitted to the BSMU Clinic in a planned manner with complaints of urinary incontinence during coughing, sneezing, and physical exertions as well as of a feeling of a foreign body in the vagina. The examination results confirmed a diagnosis of stress urinary incontinence. Comorbidities: Pelvic floor weakness. 2–3 degrees omission of the anterior vaginal wall. Cystocele. POP-Q 2. It was decided to perform a robotic-assisted Burch operation using an alloplant.Results and discussion. The postoperative period proceeded without complications. A Foley’s catheter was removed on the first day. After its removal, natural urination was restored. The stitches were removed on the fifth day. The wound healed by primary intention healing. Urine was retained well during functional tests. On the 7th and 30th days, magnetic resonance imaging (MRI) revealed no inflammatory processes at the fixation site of the allograft. The allograft was retained, its integrity was preserved, and no pathology was detected. Patient examination at a distant time after surgery (2, 4, and 12 months) revealed that the function of the bladder to hold urine was preserved.Conclusion. Robotic colposuspension using an alloplant is safe and can significantly improve quality of life indicators. The main advantages of this operation include the absence of allograft deformation and disease recurrence during patient examination as well as slighter injuries to the paraurethral tissues assisting the bladder in holding urine.
- Open Access
- 5 January 2023
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (4) , 345-349
Preventing postoperative complications after robot-assisted transabdominal preperetoneal repair: clinical case
Introduction. Inguinal hernia repair is one of the most common elective surgeries today. In our clinic, the majority of inguinal hernia repairs are performed laparoscopically. The most frequent complication after transabdominal preperitoneal inguinal hernia repair is postoperative seroma.Materials and methods. A 35-year-old patient C. with a right-sided inguinal hernia sought medical care in our clinic. He underwent robot-assisted TAPP with fluorescence lymphography using indocyanine green (ICG).Results and discussion. The present paper describes the possible relationship between intraoperative damage of the lymphatic vessels within the spermatic cord induced by robot-assisted transabdominal preperitoneal inguinal hernia repair and postoperative development of inguinal seroma. 5 mg/ml of indocyanine green was injected into the testicle on the side with the hernial bulge to visualize the lymphatic vessels. In this case such procedure is safe and feasible. Due to the tight fusion of the hernia sac with two visualized lymphatic vessels, they were excised during surgery. In the early postoperative period, an ultrasound scan revealed a subclinical seroma in the inguinal region of approximately 10 ml.Conclusion. A case series of ICG fluorescence lymphography during robot-assisted TAPP should be performed further to elucidate the relationship between lymphatic vessel damage and hydrocele.
- 5 January 2023
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (4) , 345-349
Open AccessPreventing postoperative complications after robot-assisted transabdominal preperetoneal repair: clinical case
Introduction. Inguinal hernia repair is one of the most common elective surgeries today. In our clinic, the majority of inguinal hernia repairs are performed laparoscopically. The most frequent complication after transabdominal preperitoneal inguinal hernia repair is postoperative seroma.Materials and methods. A 35-year-old patient C. with a right-sided inguinal hernia sought medical care in our clinic. He underwent robot-assisted TAPP with fluorescence lymphography using indocyanine green (ICG).Results and discussion. The present paper describes the possible relationship between intraoperative damage of the lymphatic vessels within the spermatic cord induced by robot-assisted transabdominal preperitoneal inguinal hernia repair and postoperative development of inguinal seroma. 5 mg/ml of indocyanine green was injected into the testicle on the side with the hernial bulge to visualize the lymphatic vessels. In this case such procedure is safe and feasible. Due to the tight fusion of the hernia sac with two visualized lymphatic vessels, they were excised during surgery. In the early postoperative period, an ultrasound scan revealed a subclinical seroma in the inguinal region of approximately 10 ml.Conclusion. A case series of ICG fluorescence lymphography during robot-assisted TAPP should be performed further to elucidate the relationship between lymphatic vessel damage and hydrocele.
- Open Access
- 31 December 2022
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 21 (6) , 81-90
Morphological heterogeneity of intratumoral macrophages in prostate tumors
Background. Prostate cancer (PCa) is the most common human cancer worldwide. In the progression of prostate cancer, the total number of macrophages in the tumor tissue is associated with poor prognosis and increased risk of metastasis. However, the heterogeneity of intratumoral macrophages at various stages of PCa development, and the role of tumor-associated macrophages (TAMs) have been insuffciently investigated.The aim of the study was to analyze the morphological features, size and number of TAMs in PCa tissue samples, and to reveal their correlation with clinical data of patients.Material and Methods. Immunohistochemical analysis of 36 paraffn blocks of patients with PCa (pT2a–3bN0–1M0) was performed using antibodies to the scavenger receptor CD68.Results. Foamy CD68+ macrophages were found in the tumor tissue. The indicator “number of macrophages per total number of felds of view with macrophages” was the lowest in patients with a Gleason score of 6 (5.8) (11.0 – in patients with a Gleason score ≥ 8). Macrophages formed larger clusters in patients with severe PCa. Small but not large macrophages were signifcantly more common in patients with lymph node metastases (48 vs 24 in the N0 group; p=0.14). The number of small macrophages (smaller than 100 µm2) increased in a series of patients with Gleason scores of 6, 7 and ≥ 8 (24, 47.5, 72, respectively, p=0.052).Conclusion. As the tumor process progressed and the risk of biochemical recurrence increased, there was a trend towards an increase in the total area of large, foamy TAMs, presumably rich in lipids, as well as wider distribution of small macrophages with a tendency to form clusters. We hypothesize that foamy macrophages are involved in the further recruitment of small TAMs, subsequently leading to metastasis and tumor progression.
- 31 December 2022
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 21 (6) , 81-90
Open AccessMorphological heterogeneity of intratumoral macrophages in prostate tumors
Background. Prostate cancer (PCa) is the most common human cancer worldwide. In the progression of prostate cancer, the total number of macrophages in the tumor tissue is associated with poor prognosis and increased risk of metastasis. However, the heterogeneity of intratumoral macrophages at various stages of PCa development, and the role of tumor-associated macrophages (TAMs) have been insuffciently investigated.The aim of the study was to analyze the morphological features, size and number of TAMs in PCa tissue samples, and to reveal their correlation with clinical data of patients.Material and Methods. Immunohistochemical analysis of 36 paraffn blocks of patients with PCa (pT2a–3bN0–1M0) was performed using antibodies to the scavenger receptor CD68.Results. Foamy CD68+ macrophages were found in the tumor tissue. The indicator “number of macrophages per total number of felds of view with macrophages” was the lowest in patients with a Gleason score of 6 (5.8) (11.0 – in patients with a Gleason score ≥ 8). Macrophages formed larger clusters in patients with severe PCa. Small but not large macrophages were signifcantly more common in patients with lymph node metastases (48 vs 24 in the N0 group; p=0.14). The number of small macrophages (smaller than 100 µm2) increased in a series of patients with Gleason scores of 6, 7 and ≥ 8 (24, 47.5, 72, respectively, p=0.052).Conclusion. As the tumor process progressed and the risk of biochemical recurrence increased, there was a trend towards an increase in the total area of large, foamy TAMs, presumably rich in lipids, as well as wider distribution of small macrophages with a tendency to form clusters. We hypothesize that foamy macrophages are involved in the further recruitment of small TAMs, subsequently leading to metastasis and tumor progression.
- Open Access
- 18 August 2022
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 18 (2) , 68-73
DENTAL QUALITY OF LIFE SCORE OHIP-49-RU IN PATIENTS WITH LABORATORY-CONFIRMED SARS-COV-2 DIAGNOSIS
To date, there is a limited amount of literature that describes the dental quality of life measures on the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2. Therefore, this topic is relevant. Thus, the aim of this study was to study the dental quality of life indicators according to the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2 of moderate severity, with concomitant oral co-infection. Materials and methods: a comparative analysis of quality of life indicators according to the OHIP-49-RU scale was carried out in patients with a confirmed diagnosis of SARS-CoV-2. The conclusions are drawn based on the results of the survey, in which a comparative assessment of quality of life indicators on the OHIP-49-RU scale was carried out in 90 patients aged 45 to 60 years with moderate Sars-CoV-2 with oral co-infection. Results. During the study, the following results were obtained. An analysis of the effectiveness of the use of therapeutic and prophylactic agents in patients with SARS-CoV-2 showed that the use of a 0.05% solution of chlorhexidine bigluconate in patients with Sars-CoV-2 with concomitant oral co-infection has a more pronounced antimicrobial effect, which helps to reduce the intensity of inflammatory process in the oral mucosa and periodontal tissues, improving the quality of life than with the use of Miramistin and Rotokan. Findings. The data of the conducted study will constitute an important stage for improving the quality of life in patients with SARS-CoV-2.
- 18 August 2022
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 18 (2) , 68-73
Open AccessDENTAL QUALITY OF LIFE SCORE OHIP-49-RU IN PATIENTS WITH LABORATORY-CONFIRMED SARS-COV-2 DIAGNOSIS
To date, there is a limited amount of literature that describes the dental quality of life measures on the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2. Therefore, this topic is relevant. Thus, the aim of this study was to study the dental quality of life indicators according to the OHIP-49-RU scale in patients with a confirmed diagnosis of SARS-CoV-2 of moderate severity, with concomitant oral co-infection. Materials and methods: a comparative analysis of quality of life indicators according to the OHIP-49-RU scale was carried out in patients with a confirmed diagnosis of SARS-CoV-2. The conclusions are drawn based on the results of the survey, in which a comparative assessment of quality of life indicators on the OHIP-49-RU scale was carried out in 90 patients aged 45 to 60 years with moderate Sars-CoV-2 with oral co-infection. Results. During the study, the following results were obtained. An analysis of the effectiveness of the use of therapeutic and prophylactic agents in patients with SARS-CoV-2 showed that the use of a 0.05% solution of chlorhexidine bigluconate in patients with Sars-CoV-2 with concomitant oral co-infection has a more pronounced antimicrobial effect, which helps to reduce the intensity of inflammatory process in the oral mucosa and periodontal tissues, improving the quality of life than with the use of Miramistin and Rotokan. Findings. The data of the conducted study will constitute an important stage for improving the quality of life in patients with SARS-CoV-2.
- Open Access
- 12 November 2021
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 17 (3)
FEATURES OF DENTAL STATUS OF PATIENTS WITH SARS-COV-2
At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Republic of China with an epicenter in the city of Wuhan [26]. The causative agent was given the temporary name 2019-nCoV. The World Health Organization officially named the infection-COVID-19 on February 11, 2020. The official name of the causative agent of infection SARS-CoV-2, was assigned by the international committee on the taxonomy of viruses [22]. A number of authors have established that the main role is played by receptors of angiotensin converting enzyme 2 (ACE2) in the penetration of the virus into target cells [19]. It is known that the transmission of SARS-CoV-2 occurs more often by airborne droplets during close contact with infected patients [15], as well as through direct contact with infected people and infected objects [17, 18, 20]. For healthcare professionals, SARS-CoV-2 has set tasks related to the rapid diagnosis and provision of medical care to patients. Currently, information on the clinical features, epidemiology, prevention and treatment of this disease is limited [13, 14]. To date, there is a limited amount of literature describing the dental status in patients diagnosed with SARS-CoV-2. Thus, the purpose of this study was to study the state of oral mucosa and substantiate its changes in patients with a laboratory-confirmed diagnosis of SARS-CoV-2 of mild to moderate severity, with or without concomitant oral coinfection. On the other hand, knowledge of the peculiarities of the dental status of Sars-CoV-2 patients and timely rational treatment of diseases of the oral cavity should constitute an important stage in the algorithm for their specialized therapy [2]. The work carried out a comprehensive assessment of the state of the oral cavity and the need for dental treatment in patients with Sars-CoV-2. The conclusions are based on the results of a simple observational clinical study, in which a comparative assessment of dental status indicators was carried out in 40 patients with Sars-CoV-2 and 20 somatically healthy individuals of the same sex and age.
- 12 November 2021
- Published by TIRAZH Publishing House in Actual problems in dentistry
- Vol. 17 (3)
Open AccessFEATURES OF DENTAL STATUS OF PATIENTS WITH SARS-COV-2
At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Republic of China with an epicenter in the city of Wuhan [26]. The causative agent was given the temporary name 2019-nCoV. The World Health Organization officially named the infection-COVID-19 on February 11, 2020. The official name of the causative agent of infection SARS-CoV-2, was assigned by the international committee on the taxonomy of viruses [22]. A number of authors have established that the main role is played by receptors of angiotensin converting enzyme 2 (ACE2) in the penetration of the virus into target cells [19]. It is known that the transmission of SARS-CoV-2 occurs more often by airborne droplets during close contact with infected patients [15], as well as through direct contact with infected people and infected objects [17, 18, 20]. For healthcare professionals, SARS-CoV-2 has set tasks related to the rapid diagnosis and provision of medical care to patients. Currently, information on the clinical features, epidemiology, prevention and treatment of this disease is limited [13, 14]. To date, there is a limited amount of literature describing the dental status in patients diagnosed with SARS-CoV-2. Thus, the purpose of this study was to study the state of oral mucosa and substantiate its changes in patients with a laboratory-confirmed diagnosis of SARS-CoV-2 of mild to moderate severity, with or without concomitant oral coinfection. On the other hand, knowledge of the peculiarities of the dental status of Sars-CoV-2 patients and timely rational treatment of diseases of the oral cavity should constitute an important stage in the algorithm for their specialized therapy [2]. The work carried out a comprehensive assessment of the state of the oral cavity and the need for dental treatment in patients with Sars-CoV-2. The conclusions are based on the results of a simple observational clinical study, in which a comparative assessment of dental status indicators was carried out in 40 patients with Sars-CoV-2 and 20 somatically healthy individuals of the same sex and age.
- Open Access
- 23 June 2021
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (2) , 75-82
Cystatin C as a predictor of acute renal damage after radical surgical treatment in patients with muscle-invasive bladder cancer
Purpose of the study. To assess the clinical and prognostic significance of serum and urinary cystatin C (uCys-C and sCys-C) in patients undergoing radical cystectomy (RC) in relation to AKI.Patients and methods. In this prospective study, uCys-C and sCys-C levels were measured during the first week after undergoing RC in a heterogeneous group of patients undergoing RC (n=186), mean age 59.5±11.4 years. The observation period of the patients was 6 months. The diagnosis of AKI that developed within the first week after surgery was based on the KDIGO criteria.Results. Of the 186 examined patients, 43 developed AKI according to generally accepted criteria. During the follow-up period, no patient required renal replacement therapy. AKI patients had a longer hospital stay (22.4±22.9 versus 13.0±4.1). The sCys-C levels were significantly associated with the occurrence of AKI and CKD in the long-term postoperative period and had an area under the ROC curve of 0.76 and 0.81, respectively, for predicting severe outcomes. At an optimal cut-off value of 161.17 ng/ml, sCys-C showed a sensitivity of 65 % and a specificity of 58 % for predicting AKI. The greatest increase in the concentration of sCys-C was detected 6-12 hours after surgery, followed by a decrease in the long-term follow-up.Conclusion. Peak sCys-C levels are associated with AKI and independently predict the development of AKI in patients after RC and the onset of CKD within 6 months.
- 23 June 2021
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (2) , 75-82
Open AccessCystatin C as a predictor of acute renal damage after radical surgical treatment in patients with muscle-invasive bladder cancer
Purpose of the study. To assess the clinical and prognostic significance of serum and urinary cystatin C (uCys-C and sCys-C) in patients undergoing radical cystectomy (RC) in relation to AKI.Patients and methods. In this prospective study, uCys-C and sCys-C levels were measured during the first week after undergoing RC in a heterogeneous group of patients undergoing RC (n=186), mean age 59.5±11.4 years. The observation period of the patients was 6 months. The diagnosis of AKI that developed within the first week after surgery was based on the KDIGO criteria.Results. Of the 186 examined patients, 43 developed AKI according to generally accepted criteria. During the follow-up period, no patient required renal replacement therapy. AKI patients had a longer hospital stay (22.4±22.9 versus 13.0±4.1). The sCys-C levels were significantly associated with the occurrence of AKI and CKD in the long-term postoperative period and had an area under the ROC curve of 0.76 and 0.81, respectively, for predicting severe outcomes. At an optimal cut-off value of 161.17 ng/ml, sCys-C showed a sensitivity of 65 % and a specificity of 58 % for predicting AKI. The greatest increase in the concentration of sCys-C was detected 6-12 hours after surgery, followed by a decrease in the long-term follow-up.Conclusion. Peak sCys-C levels are associated with AKI and independently predict the development of AKI in patients after RC and the onset of CKD within 6 months.
- Open Access
- 26 January 2019
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 8 (3) , 176-184
Indocyanine Green and Arginine-Glycine-Aspartic Acid Complex Used in Intraoperative Visualization during Resection of Bladder Tumour
Introduction. Bladder cancer is one of the most common malignancies in humans, causing significant economic and social damage. In the connection, it is proposed to use a highly sensitive bladder cancer detection method, which also detects residual tumours. Additionally, the method can be used to determine the boundaries of the bladder tumour, namely through intraoperative fluorescence molecular imaging. The target agent was synthesised earlier with indocyanine green-arginine-glycine-aspartic acid, which is an integrin avß3-targeted in in vitro and in vivo bladder cancer models.Materials and methods. The toxicity of indocyanine green-arginine-glycine-aspartic acid (Agac-IG) was measured using the MTT-test. Urothelial carcinoma cell lines were introduced in Female BALB/nu and MB49 mice by means of tumour xenografts via injection in the back of the elbow area. Tumour growth was observed on a daily basis and tested by magnetic resonance imaging until it became suitable for in vivo experiments. Then, all the laboratory animals were divided into 2 groups: ig and AGAk-ig (150 μl, 0.2 mg/ml for all mice). Following this, the tumour was surgically removed. The removed tissue was subjected to a fluorescent microscopy on the basis of infrared-spectrum and histologic studies.Results. Operations carried out on subcutaneous and orthotopic mouse models under the control of fluorescent imaging using AGAk-IG demonstrate the effectiveness of using a targeted tumour sample to achieve consistent and accurate RMP-resection. Operations under the control of BIC-spectrometry have demonstrated that the proposed substance can effectively help surgeons to locate tumours, determine their edges and constantly check the presence of tumour residues during surgery.Conclusion. The findings demonstrated the high efficiency of AGAk-IG as a potential molecular fluorescent agent for tumour-specific intraoperative imaging in bladder cancer resection, as well as offering great potential for further clinical studies.
- 26 January 2019
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 8 (3) , 176-184
Open AccessIndocyanine Green and Arginine-Glycine-Aspartic Acid Complex Used in Intraoperative Visualization during Resection of Bladder Tumour
Introduction. Bladder cancer is one of the most common malignancies in humans, causing significant economic and social damage. In the connection, it is proposed to use a highly sensitive bladder cancer detection method, which also detects residual tumours. Additionally, the method can be used to determine the boundaries of the bladder tumour, namely through intraoperative fluorescence molecular imaging. The target agent was synthesised earlier with indocyanine green-arginine-glycine-aspartic acid, which is an integrin avß3-targeted in in vitro and in vivo bladder cancer models.Materials and methods. The toxicity of indocyanine green-arginine-glycine-aspartic acid (Agac-IG) was measured using the MTT-test. Urothelial carcinoma cell lines were introduced in Female BALB/nu and MB49 mice by means of tumour xenografts via injection in the back of the elbow area. Tumour growth was observed on a daily basis and tested by magnetic resonance imaging until it became suitable for in vivo experiments. Then, all the laboratory animals were divided into 2 groups: ig and AGAk-ig (150 μl, 0.2 mg/ml for all mice). Following this, the tumour was surgically removed. The removed tissue was subjected to a fluorescent microscopy on the basis of infrared-spectrum and histologic studies.Results. Operations carried out on subcutaneous and orthotopic mouse models under the control of fluorescent imaging using AGAk-IG demonstrate the effectiveness of using a targeted tumour sample to achieve consistent and accurate RMP-resection. Operations under the control of BIC-spectrometry have demonstrated that the proposed substance can effectively help surgeons to locate tumours, determine their edges and constantly check the presence of tumour residues during surgery.Conclusion. The findings demonstrated the high efficiency of AGAk-IG as a potential molecular fluorescent agent for tumour-specific intraoperative imaging in bladder cancer resection, as well as offering great potential for further clinical studies.
- Open Access
- 27 June 2018
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 47 (4) , 1565-1577
Identification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer
Background/Aims: Emerging novel optical imaging techniques with cancer-specific molecular imaging agents offer a powerful and promising platform for cancer detection and resection. White-light cystoscopy and random bladder biopsies remain the most appropriate but nonetheless suboptimal diagnostic technique for bladder cancer, which is associated with high morbidity and recurrence. However, white-light cystoscopy has intrinsic shortcomings. Although current optical imaging technologies hold great potential for improved diagnostic accuracy, there are few imaging agents for specific molecular targeting. Carbonic anhydrase IX (CAIX) plays a pivotal role in tumorigenesis and tumor progression with potential value as an imaging target. Here, we investigated the feasibility of CAIX as a target and validated the diagnostic performance and significance of CAIX as an imaging agent. Methods: We first analyzed the data from The Cancer Genome Atlas (TCGA). Pairs of samples comprising bladder cancer and adjacent normal tissue were collected. All tissue samples were used for real-time PCR and immunohistochemistry to compare CAIX expression in normal and cancer tissue. Using blue-light cystoscopy, we observed the optical distribution of fluorescently labeled CAIX antibody in freshly excised human bladders and obtained random bladder biopsies to assess sensitivity and specificity. Results: The TCGA data revealed that CAIX expression was significantly higher in bladder cancer specimens than in normal tissue. The outcome was similar in quantitative real-time PCR analysis. In immunohistochemical analysis, bladder cancer specimens classified in four pathological subtypes presented a variety of positive staining intensities, whereas no benign specimens showed CAIX staining. Using blue-light cystoscopy, we distinguished bladder cancers that were mainly papillary, some variants of urothelial carcinoma, and less carcinoma in situ, from benign tissue, despite the presence of suspicious-appearing mucosa. The sensitivity and specificity for CAIX-targeted imaging were 88.00% and 93.75%, respectively. Conclusions: CAIX-targeted molecular imaging could be a feasible and adaptive alternative approach for the accurate diagnosis and complete resection of bladder cancer.
- 27 June 2018
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 47 (4) , 1565-1577
Open AccessIdentification of Carbonic Anhydrase IX as a Novel Target for Endoscopic Molecular Imaging of Human Bladder Cancer
Background/Aims: Emerging novel optical imaging techniques with cancer-specific molecular imaging agents offer a powerful and promising platform for cancer detection and resection. White-light cystoscopy and random bladder biopsies remain the most appropriate but nonetheless suboptimal diagnostic technique for bladder cancer, which is associated with high morbidity and recurrence. However, white-light cystoscopy has intrinsic shortcomings. Although current optical imaging technologies hold great potential for improved diagnostic accuracy, there are few imaging agents for specific molecular targeting. Carbonic anhydrase IX (CAIX) plays a pivotal role in tumorigenesis and tumor progression with potential value as an imaging target. Here, we investigated the feasibility of CAIX as a target and validated the diagnostic performance and significance of CAIX as an imaging agent. Methods: We first analyzed the data from The Cancer Genome Atlas (TCGA). Pairs of samples comprising bladder cancer and adjacent normal tissue were collected. All tissue samples were used for real-time PCR and immunohistochemistry to compare CAIX expression in normal and cancer tissue. Using blue-light cystoscopy, we observed the optical distribution of fluorescently labeled CAIX antibody in freshly excised human bladders and obtained random bladder biopsies to assess sensitivity and specificity. Results: The TCGA data revealed that CAIX expression was significantly higher in bladder cancer specimens than in normal tissue. The outcome was similar in quantitative real-time PCR analysis. In immunohistochemical analysis, bladder cancer specimens classified in four pathological subtypes presented a variety of positive staining intensities, whereas no benign specimens showed CAIX staining. Using blue-light cystoscopy, we distinguished bladder cancers that were mainly papillary, some variants of urothelial carcinoma, and less carcinoma in situ, from benign tissue, despite the presence of suspicious-appearing mucosa. The sensitivity and specificity for CAIX-targeted imaging were 88.00% and 93.75%, respectively. Conclusions: CAIX-targeted molecular imaging could be a feasible and adaptive alternative approach for the accurate diagnosis and complete resection of bladder cancer.